Home › Trial NCT00895726
Pilot Study of APD209 in Cancer Cachexia
- Trial IDNCT00895726
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAcacia Pharma Ltd
- Enrollment13
- Start date2009-03
- ConditionsCancer-related Cachexia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.